Vera Bittner

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial”.

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

Journal of the American Heart Association(2023)10.1161/jaha.122.029216

N/A

1.1DataRank · unranked

40 citations

Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +10 more

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

European Journal of Preventive Cardiology(2022)10.1093/eurjpc/zwac107

N/A

0.846DataRank · unranked

15 citations

Jennifer McGinniss, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +12 more

Hybrid cardiac rehabilitation – The state of the science and the way forward

Progress in Cardiovascular Diseases(2022)10.1016/j.pcad.2021.12.004

N/A

0.646DataRank · unranked

73 citations

Luke Ramirez, Luke Joseph, Stephen Clarkson, Randal Thomas, Vera Bittner +1 more

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae025

N/A

0.483DataRank · unranked

24 citations

Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +82 more

Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.02.016

N/A

0.401DataRank · unranked

5 citations

Patrícia O. Guimarães, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj +13 more

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial

Diabetes Care(2025)10.2337/dc24-2110

N/A

0.360DataRank · unranked

10 citations

Michael Szarek, J. Wouter Jukema, Christa M. Cobbaert, Esther Reijnders, Vera Bittner +9 more

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study

Kidney Medicine(2021)10.1016/j.xkme.2021.04.008

N/A

0.241DataRank · unranked

4 citations

Robert S. Rosenson, Vera Bittner, Orlando M. Gutiérrez, Amanda H. Anderson, Mark Woodward +10 more

Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

Kidney Medicine(2023)10.1016/j.xkme.2023.100648

N/A

0DataRank · unranked

9 citations

Robert S. Rosenson, Shia T. Kent, Vera Bittner, Orlando M. Gutiérrez, Amanda H. Anderson +11 more

Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women’s Ischemia Syndrome Evaluation (WISE) Cohort

Canadian Journal of Cardiology(2023)10.1016/j.cjca.2023.08.010

N/A

0DataRank · unranked

4 citations

Galen Cook‐Wiens, Carl J. Pepine, Eileen Handberg, Steven E. Reís, Vera Bittner +4 more

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

Journal of clinical lipidology(2024)10.1016/j.jacl.2024.08.013

N/A

0DataRank · unranked

84 citations

Nicholas Marston, Kevin C. Maki, Terry A. Jacobson, Vera Bittner, Jessica M. Peña +8 more

Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2023.11.008

N/A

0DataRank · unranked

21 citations

Vera Bittner, Sotirios Tsimikas

Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease

American Heart Journal Plus Cardiology Research and Practice(2024)10.1016/j.ahjo.2024.100376

N/A

0DataRank · unranked

5 citations

Yujie Cui, Amer Muhyieddeen, Okezi Obrutu, Janet Wei, Martha Gulati +6 more

Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women's Ischemia Syndrome Evaluation (WISE) study

American Heart Journal Plus Cardiology Research and Practice(2024)10.1016/j.ahjo.2024.100411

N/A

0DataRank · unranked

1 citations

Ankur Jain, Yasmeen Taha, Eileen Handberg, B. Delia Johnson, Vera Bittner +5 more

In memoriam: A tribute to Linda Hemphill

Journal of Clinical Lipidology(2025)10.1016/j.jacl.2025.05.011

N/A

0DataRank · unranked

0 citations

Vera Bittner, Pamela B. Morris, Anne Carol Goldberg

Incident CHD and ischemic stroke associated with lipoprotein(a) by levels of Factor VIII and inflammation

Journal of clinical lipidology(2023)10.1016/j.jacl.2023.06.001

N/A

0DataRank · unranked

12 citations

Sascha N. Goonewardena, Zhixin Wang, Elizabeth A. Jackson, Michael E. Farkouh, Mei Li +7 more

Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction

Journal of clinical lipidology(2021)10.1016/j.jacl.2021.11.001

N/A

0DataRank · unranked

7 citations

Vera Bittner, T M Brown, L Chen, Lisandro D. Colantonio, Jason Exter +5 more

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction

UNC Libraries(2021)10.17615/53p3-sw38

N/A

0DataRank · unranked

0 citations

Salim Yusuf, Sylvie A. Ahn, William J. Rogers, Eleanor Schron, Philip N. Gallagher +5 more

Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women's Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects

Heart and Mind(2022)10.4103/hm.hm_35_22

N/A

0DataRank · unranked

12 citations

David S. Krantz, Vera Bittner, C. Noel Bairey Merz, Steven E. Reís, Eileen Handberg +4 more

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline

American Heart Journal Plus Cardiology Research and Practice(2022)10.1016/j.ahjo.2022.100201

N/A

0DataRank · unranked

14 citations

Vera Bittner, Todd M. Brown, Lisandro D. Colantonio, Nafeesa Dhalwani, Jenna Jones +10 more

Characteristics of patients with diabetes and a history of myocardial infarction initiating PCSK9 and SGLT2 inhibitors

American Heart Journal Plus Cardiology Research and Practice(2022)10.1016/j.ahjo.2022.100121

N/A

0DataRank · unranked

2 citations

Emily McKinley, Lisandro D. Colantonio, Bharat Poudel, Robert S. Rosenson, Todd M. Brown +8 more

Persistent chest pain at 1-year predicts long-term angina hospitalization in women with and without obstructive coronary artery disease: results from Women's Ischemia Syndrome Evaluation (WISE)

European Heart Journal(2020)10.1093/ehjci/ehaa946.3186

N/A

0DataRank · unranked

1 citations

Janet Wei, Nissi Suppogu, Galen Cook‐Wiens, S. F. Kelsey, Vera Bittner +8 more